Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FD6U9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $76,950
Award facts
- Contract value 100% obligated
- $76,950.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $76,950.36 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This contract is classified as firm fixed price with no set-aside designation and represents a competitively awarded delivery order with an ultimate completion date of July 29, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Logistics Agency. The company's federal contract portfolio demonstrates extensive capability in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The larger SPE2DX vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply diverse medical products to support military healthcare programs worldwide, with the Defense Logistics Agency currently planning additional Pharmaceutical Prime Vendor Global Program Generation V contracts that may involve multiple regional awards.
Quick answers
Who was awarded contract SPE2DB25FD6U9?
SPE2DB25FD6U9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 28, 2025.
How much is contract SPE2DB25FD6U9 worth?
The government has obligated $76,950 on SPE2DB25FD6U9.
Is contract SPE2DB25FD6U9 an order under another contract?
Yes. SPE2DB25FD6U9 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FD6U9 competed?
The extent of competition for SPE2DB25FD6U9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award